| Latest Forum Topics / Trendlines Last:0.061 -- |
 Post Reply
|
|
Time to buy !
|
|||||
|
Stocky901
Supreme |
22-Apr-2026 09:04
|
||||
|
x 0
x 0 Alert Admin |
Lai liao.. don't short? 🤔 | ||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
22-Apr-2026 08:33
|
||||
|
x 0
x 1 Alert Admin |
For info Mondele z International owns Cadbury. So that itself speaks volume
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
SmallSmall
Supreme |
21-Apr-2026 17:34
|
||||
|
x 0
x 2 Alert Admin |
Mondelē z International has used Celleste Bio&rsquo s cell-based cocoa butter to create nearly a dozen milk chocolate bars, a milestone moment for the cellular agriculture industry.Cell-based chocolate is no longer a pipe dream &ndash and one of the world&rsquo s largest confectionery companies is leading the charge. Mondelē z International has developed nearly a dozen milk chocolate bars with cell-based cocoa butter from Israeli startup Celleste Bio, in which the Cadbury owner has been an investor since 2022. Celleste Bio develops the fat using real cocoa cells grown in suspension in a bioreactor. The process takes one to two beans to produce the same amount of cocoa butter that traditionally requires four tonnes of cocoa and 10,000 sq m of land. The Mondelē z innovation is proof that its technology works at scale and meets the consumption standards of an industry giant. Celleste Bio said it sets the stage for scaling up production to market-ready quantities within the next two years. &ldquo It delivers the same texture, melt, and experience as conventional cocoa &ndash and marks a real step toward scalable, commercially viable production,&rdquo CEO Michal Beressi Golomb said in a LinkedIn post. Celleste Bio&rsquo s AI-led process can create customised cocoa butter Courtesy: Celleste Bio Founded in 2022 by Hanne Volpin, Orna Harel, Avishay Levy and Daphna Michaeli, with support from The Trendlines Group, Celleste Bio pairs agtech and biotech with computational artificial intelligence (AI) to produce cocoa ingredients via cell culture. It selects different varieties of cocoa beans, extracts their cells, and grows them in a bioreactor with vitamins, minerals, water and sugar. This then becomes a biomass, from which it extracts cocoa butter and powder. The process is similar to cocoa production in nature, but in a controlled setting under optimal conditions. Importantly, the cells keep growing after the biomass is removed, so the process repeats without needing another bean. The company says its AI-led model is designed to customise cocoa butter to its clients&rsquo specifications, such as higher melting points and taste experiences, which can allow them to level up their innovation and competitive advantage. &ldquo Celleste launched in 2022 with the mission to secure a sustainable future for the global chocolate industry amidst increasing supply chain pressures of climate change, disease, traceability and geopolitical instability,&rdquo said Beressi Golomb. &ldquo In three years, we&rsquo ve made unprecedented progress to meet this formidable scientific challenge. We&rsquo ve validated our ingredients as drop-in replacements, created an operational R& D pilot facility to scale up our volumes and now proven our cocoa butter performs identically to conventional cocoa, clearing the next phase to commercial scale.&rdquo Celleste Bio aims to be market-ready by 2027 Courtesy: Celleste Bio According to Celleste Bio, chocolate manufacturers spend about $16B on cocoa ingredients each year, and cocoa butter alone accounts for nearly half of that. And althouth crop yields and prices can level out at times, long-term instability is almost a given without tech-forward solutions. And instability is exactly what has plagued the cocoa industry. Climate change pushed cocoa stocks to their lowest levels in a decade and prices to all-time highs in 2024. Extreme weather and crop diseases have hit plantations hardest in the Ivory Coast and Ghana, the two largest cocoa producers, which have already lost over 85% of their forest cover since 1960. Scientists warn that a third of the world&rsquo s cocoa trees could die out by 2050. Plus, producing chocolate emits more greenhouse gases than any other food except beef, and the industry is linked to widespread tropical deforestation. &ldquo Building a resilient supply chain means being able to produce at commercial volumes while offsetting disruptions caused by climate change, deforestation and resource scarcity,&rdquo said Celleste Bio&rsquo s chief science and technology officer, Hanne Volpin. &ldquo We are on track to produce one tonne of cocoa butter annually in a 1000-litre bioreactor from a single bean &ndash which would otherwise require about a hectare of cocoa trees. To that end, we&rsquo ve curated a very robust bank of multiple cocoa bean varietals we can use to grow, test and scale material without ever having to cut down a single tree in the rainforest.&rdquo Speaking to Green Queen in October, Beressi Golomb revealed that the company is finalising its pilot facility and anticipates being market-ready by 2027. It&rsquo s currently awaiting approval in the US, the UK, the EU, and Israel. &ldquo The ingredient is and must be at parity with cocoa prices, ideally more cost-efficient when traditional cocoa supply is skyrocketing,&rdquo she said at the time. &ldquo We have two parts of the business: a drop-in replacement, which will be more on par with market costs and premium cocoa, which will be priced for the premium market.&rdquo The startup has already raised $5.6M to date, and is one of several cell-based cocoa innovators being backed by Big Chocolate. Sparkalis, the VC arm of Belgian confectionery giant Puratos, has been an investor in California Cultured from an early stage, and intends to make a cell-based chocolate product available to its clients by the end of the year. Puratos and Lindt are also investors in Switzerland&rsquo s Food Brewer, and Cargill is working on applications with fellow Israeli startup Kokomodo. |
||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
21-Apr-2026 17:14
|
||||
|
x 0
x 2 Alert Admin |
Unfortunately no matching price. If not can buy now Trendlines Portfolio Company Celleste Bio&trade Unveils World' s First Milk Chocolate Bars Made with Cell Cultured Cocoa Butter &bull This achievement positions Celleste to scale its operations, with market-ready cell cultured cocoa butter anticipated by 2027. &bull Founded and incubated by Trendlines, Trendlines holds a 17% stake in Celleste Misgav, Israel &ndash 21 April 2026 &ndash The Trendlines Group Ltd. (SGX: 42T OTCQX: TRNLY), an investment group focused on agrifood and medtech innovation, is thrilled to announce that portfolio company Celleste Bio&trade (&ldquo Celleste&rdquo ) unveiled the world' s first milk chocolate bars made with real cocoa butter using cell suspension culture technology. This marks a significant advancement for Celleste in accelerating its ability to build a scalable and commercially viable cocoa supply. Mondelē z International used the cocoa butter from Celleste to produce almost twelve chocolate bars that met its product standards. Celleste can produce enough chocolate grade cell cultured cocoa butter for chocolate bars using only a single cocoa bean. Celleste, founded in 2022, has over the past three years achieved significant milestones, including validating its cell cultured cocoa butter as a direct alternative to traditional cocoa, establishing a pilot facility for scaling production, and demonstrating that its product matches the quality and performance of conventional cocoa butter. These accomplishments have positioned Celleste to move toward commercial-scale operations. Celleste intends to transform the chocolate market by using AI modelling to tailor cocoa butter for specific melting points and flavour profiles, giving manufacturers a boost in innovation and competitiveness. Celleste is developing a resilient supply chain by achieving commercial-scale cocoa butter production in a 1000-liter bioreactor using only a single cocoa bean. This process eliminates the sole dependence on the traditional farming of cocoa trees and supplements production, without replacing it. Celleste has established a diverse bank of cocoa bean varieties for testing and scaling production, ensuring sustainable growth without harming natural resources. To date, Celleste has raised US$5.6 million from various investors, including Mondelē z International as a strategic and design partner, along with The Trendlines Group, Supply Change Capital, Barrel Ventures, Consensus Business Group and other non-dilutive grants. Trendlines&rsquo Executive Director and CEO Haim Brosh commented, &ldquo This milestone demonstrates Celleste' s cell cultured ingredients are bio-identical to conventionally grown cocoa - meaning they deliver the same texture, melt profile and sensory experience, and sets the stage for scaling production to market-ready quantities in the foreseeable future. |
||||
| Useful To Me Not Useful To Me | |||||
|
newbie1118
Master |
14-Apr-2026 14:56
|
||||
|
x 0
x 0 Alert Admin |
Finally waking up? | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
newbie1118
Master |
14-Apr-2026 12:05
|
||||
|
x 0
x 0 Alert Admin |
Accumulate when everybody is scared. | ||||
| Useful To Me Not Useful To Me | |||||
|
Newbie85
Veteran |
14-Apr-2026 11:52
|
||||
|
x 0
x 0 Alert Admin |
https://www.nextinsight.net/story-archive-mainmenu-60/948-2025/16424-trendlines-ceo-on-why-therell-be-multiplication-of-returns-when-exits-happen | ||||
| Useful To Me Not Useful To Me | |||||
|
Newbie85
Veteran |
14-Apr-2026 11:43
|
||||
|
x 0
x 1 Alert Admin |
Trendline have to pick up for surprise exits. not for weak holders. maybe they see IX they also cannot tahan. once exit will be a crazy counter |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
SmallSmall
Supreme |
13-Apr-2026 08:50
|
||||
|
x 0
x 1 Alert Admin |
The story for Trendline is pretty similar to IX. They just need to commercialise their Phytolon, a biotech-foodtech startup that offers natural food colors via fermentation of baker&rsquo s yeast to have analysts scrambling to revise the target price. And min you ,Phytolon has already gotten FDA approval.
|
||||
| Useful To Me Not Useful To Me | |||||
|
beachlover1270
Member |
12-Apr-2026 12:30
|
||||
|
x 0
x 1 Alert Admin |
Trendlines may surge one day like IX Biopharma once it announces " huge exits for its portfolio companies" . Can buy some and hold in the meantime. Watch and monitor it closely. | ||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
10-Apr-2026 16:45
|
||||
|
x 0
x 2 Alert Admin |
$0.059 liao $0.003
|
||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
08-Apr-2026 13:03
|
||||
|
x 0
x 1 Alert Admin |
This one should gradually recover as the War winds down.....$0.054 unchanged
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Stocky901
Supreme |
06-Apr-2026 14:22
|
||||
|
x 0
x 0 Alert Admin |
Can't go up unless they willing to stop the war.. 🧐 | ||||
| Useful To Me Not Useful To Me | |||||
|
TraderBen
Supreme |
06-Apr-2026 11:09
|
||||
|
x 0
x 0 Alert Admin |
business in war zone leh.. if T decides IsR go its own way.. the country is doomed..
|
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
06-Apr-2026 10:30
|
||||
|
x 0
x 0 Alert Admin |
Now back in the black, SGX-listed Trendlines doubles down on core bets The group is concentrating on assets in its strongest portfolio companies, says CEO Haim Brosh [SINGAPORE] Having returned to profitability in FY2025, startup incubator The Trendlines Group : 42T +1.96% is now narrowing its focus, with an eye towards scaling its most promising portfolio companies. To focus its resources accordingly, the Catalist-listed company has in recent years shifted away from broad venture-building, halting new investments and exiting non-core businesses. &ldquo We are concentrating on our assets in (our strongest) portfolio companies, promoting them, helping them grow from where they were from up until their exits,&rdquo Haim Brosh, executive director and chief executive officer at Trendlines, told The Business Times in a video call from Tel Aviv. Since assuming the CEO role about two-and-a-half years ago, Brosh has led a strategic pivot aimed at streamlining operations and improving returns. The group has since reduced operating costs by &ldquo more than 50 per cent, almost 60 per cent&rdquo , he said. Prioritising capital allocation towards high-potential portfolio companies has led to stronger fundraising outcomes and higher valuations, he added. Return to profitability Trendlines&rsquo refocus appears to be translating into financial results. For the financial year ended Dec 31, 2025, it recorded a net profit of US$1.9 million, reversing from a loss of US$9.4 million a year earlier. This turnaround was supported by a US$7.1 million net gain in the fair value of its portfolio companies, and an uplift of about US$15 million from favourable fundraising terms and business progress. The group also raised about S$6.4 million through private placements during the year. Though Brosh described the profit as modest, he said that it also marked a &ldquo pivotal turnaround&rdquo . The group&rsquo s portfolio companies also recorded a strong year in external fundraising, with notable rounds completed by firms such as crop protection firm IBI-Ag, biotech-foodtech startup Phytolon, and women&rsquo s health firm Escala Medical. Trendlines has 41 portfolio companies in total, including Singapore-based medtech startups EndoSiq and Nice Surgical. &ldquo Raising capital for Trendlines enables us to raise funds for our portfolio companies at higher valuations, which in turn drives valuation gains and supports their continued growth,&rdquo explained Brosh. As external investment into its portfolio reaches record levels, he said that the group remains focused on positioning its companies for strategic exits and delivering long-term value in 2026 and beyond. Addressing governance challenges The group has also had to navigate governance issues. In 2024, Trendlines terminated Anton Wibowo, the CEO of its subsidiary Trendlines Agrifood Innovation Centre in Singapore, over the alleged misappropriation of about US$2.1 million. Brosh described the incident as &ldquo an unfortunate event&rdquo and one of the most significant challenges he has faced. He travelled to Singapore &ldquo hours after&rdquo learning of the situation, to oversee the response, engage stakeholders and stop any further loss of funds. A special committee was formed external investigators were also appointed alongside internal and external auditors to review processes and identify control gaps. &ldquo It was very severe, and we have implemented, by now, all the recommendations of the internal auditors and the external investigator,&rdquo Brosh noted. As the incident unfolded, he prioritised transparent communication with shareholders, ensuring they were fully informed about the situation and the measures taken. He added: &ldquo Seeing the support of the shareholders post the event showed that we probably did the right things and we managed it properly.&rdquo That confidence is reflected in Trendlines&rsquo focus on generating returns. Shareholders remain a key priority for the group, with profits from the portfolio companies intended to deliver returns. Brosh acknowledged that the group operates in a high-risk business, building companies from the ground up. He pointed out that not all portfolio companies are expected to succeed, with some inevitably being written off along the way. &ldquo The expectation is that the best companies&rsquo profit will be so high that we create profit (for) our shareholders.&rdquo |
||||
| Useful To Me Not Useful To Me | |||||
|
Tob231
Elite |
27-Mar-2026 10:04
|
||||
|
x 0
x 0 Alert Admin |
haha ... that is the way ... you want come and have it ... 0.057 ... go higher | ||||
| Useful To Me Not Useful To Me | |||||
|
Tob231
Elite |
27-Mar-2026 09:05
|
||||
|
x 0
x 0 Alert Admin |
rock solid despite being at the centre of the conflict, no panic, hold steady those weak hands already released. wait for them to come back and buy up |
||||
| Useful To Me Not Useful To Me | |||||
|
LoudShout
Master |
25-Mar-2026 09:55
|
||||
|
x 0
x 0 Alert Admin |
The warmongers must pay the costs of destructions, loss of human lives, sufferings and the whole world is affected like innocent people in SEA the food vendors, hail drivers, etc.. with disruptions in oil, fertilizers, etc..
|
||||
| Useful To Me Not Useful To Me | |||||
|
Stocky901
Supreme |
25-Mar-2026 09:30
|
||||
|
x 0
x 0 Alert Admin |
Even US stops bombing Iran, Israel will still continue.. they are addicted to fighting & killing.. 😢
|
||||
| Useful To Me Not Useful To Me | |||||
|
LoudShout
Master |
25-Mar-2026 09:27
|
||||
|
x 0
x 0 Alert Admin |
since IPO at 31 cents, no dividends... only private placements and many so called breakthroughs. Dont expect much from this counter, if good they would list in US. | ||||
| Useful To Me Not Useful To Me | |||||